Jinkui Yang

机构：Beijing Tongren Hospital, Capital Medical University · ORCID：0000-0002-7252-8109

发表论文 17 篇 · 总被引 612 次 · h-index 8

代表论文

• Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis (2022 · Diabetes Care · 被引 207)
• Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease (2021 · Stroke · 被引 121)
• Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes (2023 · Annals of Internal Medicine · 被引 94)
• Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial (2023 · American Journal of Kidney Diseases · 被引 29)
• Efficacy and safety of alogliptin in patients with type 2 diabetes mellitus: A multicentre randomized double‐blind placebo‐controlled Phase 3 study in mainland China, Taiwan, and Hong Kong (2016 · Journal of Diabetes · 被引 27)
• Determining the optimal fasting glucose target for patients with type 2 diabetes: Results of the multicentre, open‐label, randomized‐controlled FPG GOAL trial (2019 · Diabetes Obesity and Metabolism · 被引 17)